Authors: Russell, KE Read, MS Bellinger, DA Leitermann, K Rup, BJ McCarthy, KP Keith, JC Khor, SP Schaub, RG Nichols, TC

Citation: Ke. Russell et al., Intratracheal administration of recombinant human factor IX (BeneFix (TM))achieves therapeutic levels in hemophilia B dogs, THROMB HAEM, 85(3), 2001, pp. 445-449

Authors: Wang, LL Nichols, TC Read, MS Bellinger, DA Verma, IM

Citation: Ll. Wang et al., Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver, MOL THER, 1(2), 2000, pp. 154-158

Authors: Herzog, RW Yang, EY Couto, LB Hagstrom, JN Elwell, D Fields, PA Burton, M Bellinger, DA Read, MS Brinkhous, KM Podsakoff, GM Nichols, TC Kurtzman, GJ High, KA

Citation: Rw. Herzog et al., Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, NAT MED, 5(1), 1999, pp. 56-63

Authors: Snyder, RO Miao, C Meuse, L Tubb, J Donahue, BA Lin, HF Stafford, DW Patel, S Thompson, AR Nichols, T Read, MS Bellinger, DA Brinkhous, KM Kay, MA

Citation: Ro. Snyder et al., Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors, NAT MED, 5(1), 1999, pp. 64-70

Authors: Chao, H Samulski, RJ Bellinger, DA Monahan, PE Nichols, TC Walsh, CE

Citation: H. Chao et al., Persistent expression of canine factor IX in hemophilia B canines, GENE THER, 6(10), 1999, pp. 1695-1704

Authors: Nichols, TC du Laney, T Zheng, B Bellinger, DA Nickols, GA Engleman, W Clemmons, DR

Citation: Tc. Nichols et al., Reduction in atherosclerotic lesion size in pigs by alpha V beta 3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling, CIRCUL RES, 85(11), 1999, pp. 1040-1045